ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 2: NeoplasmsD34

D34

Billable

Benign neoplasm of thyroid gland

Chapter 2:Neoplasms

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D34 is a billable code used to indicate a diagnosis of benign neoplasm of thyroid gland.

Key Diagnostic Point:

Benign neoplasms of the thyroid gland, classified under ICD-10 code D34, refer to non-cancerous growths that arise from the thyroid tissue. These neoplasms can manifest as solitary nodules or multinodular goiters and are often discovered incidentally during imaging studies or physical examinations. Clinically, patients may present with a palpable mass in the neck, changes in voice, or symptoms of hyperthyroidism if the neoplasm produces excess thyroid hormones. The majority of benign thyroid neoplasms are follicular adenomas, which are encapsulated tumors that do not invade surrounding tissues. Diagnosis typically involves a combination of clinical evaluation, ultrasound imaging, and fine-needle aspiration biopsy to rule out malignancy. Management may include observation, hormone therapy, or surgical intervention depending on the size, symptoms, and patient preference. Regular monitoring is essential to ensure that any changes in the neoplasm's characteristics are promptly addressed, as some benign tumors can exhibit atypical features that warrant further investigation.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between benign and malignant thyroid conditions
  • Need for precise documentation of imaging and biopsy results
  • Variability in clinical presentation among patients
  • Potential for co-existing thyroid disorders

Audit Risk Factors

  • Inadequate documentation of diagnostic imaging
  • Failure to document the size and characteristics of the neoplasm
  • Misclassification of benign neoplasms as malignant
  • Lack of follow-up documentation for surveillance

Specialty Focus

Medical Specialties

Endocrinology

Documentation Requirements

Thorough documentation of clinical findings, imaging results, and biopsy reports is essential.

Common Clinical Scenarios

Patients presenting with thyroid nodules, hyperthyroidism symptoms, or incidental findings on imaging.

Billing Considerations

Endocrinologists must ensure that all relevant lab results and imaging studies are included in the patient's record to support the diagnosis.

Surgery

Documentation Requirements

Detailed operative reports and post-operative follow-up notes are critical.

Common Clinical Scenarios

Surgical intervention for large or symptomatic thyroid nodules.

Billing Considerations

Surgeons should document the rationale for surgery and any findings during the procedure that may affect coding.

Coding Guidelines

Inclusion Criteria

Use D34 When
  • According to the official coding guidelines, D34 should be used when a benign neoplasm of the thyroid gland is confirmed through appropriate diagnostic procedures
  • It is important to document the specific type of neoplasm and any associated symptoms or complications

Exclusion Criteria

Do NOT use D34 When
No specific exclusions found.

Related CPT Codes

60100CPT Code

Thyroid biopsy, fine needle aspiration

Clinical Scenario

Used when a thyroid nodule is evaluated for malignancy.

Documentation Requirements

Document the indication for the biopsy and the results.

Specialty Considerations

Endocrinologists and surgeons should ensure that the biopsy results are clearly linked to the diagnosis.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of benign thyroid neoplasms, improving the accuracy of data collection and reimbursement processes. The granularity of ICD-10 codes helps in better tracking of thyroid conditions and their management.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of benign thyroid neoplasms, improving the accuracy of data collection and reimbursement processes. The granularity of ICD-10 codes helps in better tracking of thyroid conditions and their management.

Reimbursement & Billing Impact

reimbursement processes. The granularity of ICD-10 codes helps in better tracking of thyroid conditions and their management.

Resources

Clinical References

  • •
    American Thyroid Association Guidelines

Coding & Billing References

  • •
    American Thyroid Association Guidelines

Frequently Asked Questions

What is the difference between a benign neoplasm and a malignant neoplasm of the thyroid?

A benign neoplasm, such as a follicular adenoma, is non-cancerous and does not invade surrounding tissues, while a malignant neoplasm, such as thyroid cancer, is cancerous and has the potential to spread to other parts of the body.